Suchergebnisse - "Silva, Arnold L"

PubPharm (17)

1

Rilparencel (Renal Autologous Cell Therapy-REACT®) for Chronic Kidney Disease and Type 1 and 2 Diabetes : Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers

enthalten in: American journal of nephrology | 2024

von Stavas, J. | Silva, A. | Wooldridge, T. | +4

2

Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients : Results from the OPTIMIZE Study

enthalten in: Kidney360 | 2024

von Sprague, S. | Weiner, D. | Tietjen, D. | +12

3

Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis : the NORMALIZE Study

enthalten in: Kidney360 | 2023

von Silva, A. | Chertow, G. | Hernandez, G. | +5

4

Effects of Bardoxolone Methyl in Alport Syndrome

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2022

von Warady, B. | Pergola, P. | Agarwal, R. | +21

CommentIn: Clin J Am Soc Nephrol. 2022 Dec;17(12):1713-1715. - PMID 36411059

5

Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease : Clinical Trial Design

enthalten in: American journal of nephrology | 2022

von Stavas, J. | Gerber, D. | Coca, S. | +6

6

Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis : A 52-Week Randomized Phase 3 Trial (PHREEDOM)

enthalten in: Kidney360 | 2021

von Block, G. | Bleyer, A. | Silva, A. | +5

7

Study Design and Baseline Characteristics of the CARDINAL Trial : A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome

enthalten in: American journal of nephrology | 2021

von Chertow, G. | Appel, G. | Andreoli, S. | +18

8

Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

enthalten in: Cardiorenal medicine | 2019

von Rizk, D. | Silva, A. | Pergola, P. | +7

CommentIn: Cardiorenal Med. 2019;9(5):334-336. - PMID 31357201

9

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease

enthalten in: Journal of diabetes and its complications | 2018

von Chertow, G. | Appel, G. | Block, G. | +12

10

Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease

enthalten in: American journal of nephrology | 2015

von Sprague, S. | Silva, A. | Al-Saghir, F. | +7